GLOBAL CAMMERCIAL COOPERATION STRATEGY
Accelerating the registration,development,and marking of China’s high-quality drugs in global markets based on Kexing Biopharm’s overseas sales advantages and cooperation with China’s local pharmaceutical companies
Strong marketing capacity and early overseas layout 40+ fot marker access,60+ for registration,100+ for customer agency.
Strategy: Make Kexing Biopharm the most influential overseas professional commercial platform in the pharmaceutical field With high brand added-values
Area - Global Market
Layouts at an earlier time: Professional regulation team familiar with local regulations and markets
Layouts in a wide range of regions: Europe, Asia, America, and Africa
Diseases: Oncology &immunological, and endocrine
Types:: monoclonal antibody drugs, bispecific antibody drugs, small molecule drugs, nucleic acid drugs, and polypeptide drugs
Challenges: regulatory requirements, market changes, globalization, quality systems...
Capability: R&D of innovator drugs, production at high-quality/high-standard, cost advantages - exploring the global market
Comprehensive Commercial Cooperation
Market analysis, registration, clinical studies, sales and audi
10+ years of long-term cooperation at a trade price
Cooperation for products, industrial strategy, and industrialization
Focus on global emerging markets for a long period of time
Southeast Asia, South America, North Africa, Russia...
Pass the review of all GMP-related documents with approved applications for market access in many countries